University of Wisconsin
School of Medicine and Public Health

Research Training

As a core component of fellowship training at the UW, fellows spend roughly half of their time participating in research and pathway development. Depending on their interest, this can be clinical, basic science, or translational research; as such, fellows may develop independent research projects and/or participate in existing projects of ID Division members or of any other investigators on campus. Fellows have worked in research laboratories in the Departments of Biochemistry, Microbiology and Immunology, Pharmacology, Bacteriology, Public Health, and in the State Division of Health.

Image
Research day

All fellows have the opportunity to attend and present at several annual infectious disease conferences hosted by ASM, IDSA, SHEA, and others. Fellows also participate in the annual Department of Medicine Research Day and the UW Health Quality Improvement Symposium. Over the years, our fellows have co-authored more than 50 research publications and have been invited to submit monographs, chapters and/or abstracts at peer-reviewed national and international scientific meetings.

By graduation, most fellows have co-authored 3-5 papers and numerous have won prestigious national research awards including the Pearl M. Stetler Award, SHEA Outstanding Trainee Awards, NIH Mentored Clinical Scientist Development Award, Fellow of the American College of Physicians, and NIH Loan Repayment Awards, among many others. Fellows displaying an aptitude for research may be offered an additional training year dedicated to full-time investigation.

Since 1980 87% of our fellows entered academic careers upon completion of their fellowship and five are considered international authorities in a major area of infectious disease or microbiologic research.

    INFECTIOUS DISEASE DIVISION RESEARCH OPPORTUNITIES

    The Infectious Disease division leads research across a broad spectrum of pathogens and disease states. Research approaches include epidemiology, outcomes research, drug-resistance and drug discovery/development, basic disease pathogenesis, and immunology. Members of the division compose just a fraction of the collaborative microbial sciences research on the UW campus that exists in numerous departments and colleges. The UW microbial sciences research program was ranked in the top two nationally by US World and News Reports in 2019.

    Current research opportunities

    Image
    research

    COVID, antimicrobial drug resistance, antimicrobial stewardship, antimicrobial drug discovery, antimicrobial pharmacokinetics and pharmacodynamics, infection control and prevention, C difficile, fungal infections, transplant infectious diseases, HIV, HCV, infectious disease and social justice, global health, microbiome, virology, diabetic foot infections, biofilm infections, and immunology.

    Recent Learner Publications

    Kessler MA (fellow), Joachim EL, Narayanan D, Medani S, Urban AW, Parajuli S. On the tip of my tongue: A 76-year-old female kidney transplant patient with tongue ulcer. Transpl Infect Dis. 2020 Jun 25:e13389. doi: 10.1111/tid.13389.

    Jasper AS, Musuuza JS, Tischendorf JS (fellow), Stevens VW, Gamage SD, Osman F, Safdar N.  Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis. Clin Infect Dis. 2020 Apr 16:ciaa441. doi: 10.1093/cid/ciaa441. Online ahead of print.PMID: 32296816

    Horton MV (graduate student), Johnson CJ, Kernien JF, Patel TD, Lam BC, Cheong JZA, Meudt JJ, Shanmuganayagam D, Kalan LR, Nett JE. Candida auris Forms High-Burden Biofilms in Skin Niche Conditions and on Porcine Skin. mSphere. 2020 Jan 22;5(1):e00910-19. doi: 10.1128/mSphere.00910-19.PMID: 31969479 

    Pop-Vicas A, Stern R (resident), Osman F, Safdar N.  Variability in infection surveillance methods and impact on surgical site infection rates. Am J Infect Control. 2020 Jul 2:S0196-6553(20)30635-0. doi: 10.1016/j.ajic.2020.06.211. Online ahead of print.PMID: 32622837

    More Learner Publications

    Zelenski AB, Tischendorf JS (fellow), Kessler M (fellow), Saunders S, MacDonald MM, Vogelman B, Zakowski L.J  Beyond "Read More": An Intervention to Improve Faculty Written Feedback to Learners. Grad Med Educ. 2019 Aug;11(4):468-471. doi: 10.4300/JGME-D-19-00058.1.PMID: 31440343

    Tischendorf JS (fellow), Knobloch MJ, Musuuza JS, Safdar N. Using a Systems Engineering Framework to Evaluate Proton Pump Inhibitor Prescribing in Critically Ill Patients. J Healthc Qual. 2020 Jul/Aug;42(4):e39-e49. doi: 10.1097/

    McCreary EK (resident), Bayless M, Van AP, Lepak AJ, Wiebe DA, Schulz LT, Andes DR. Impact of Triazole Therapeutic Drug Monitoring Availability and Timing. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01245-19. doi: 10.1128/AAC.01245-19. Print 2019 Oct.PMID: 31332058 

    Hovel EM, Pease RC (fellow), Scarano AJ, Chen DJ, Saddler CM. Bordetella pertussis in a four-time kidney transplant recipient: A call for immunization programs at transplant centers. Transpl Infect Dis. 2019 Aug;21(4):e13120. doi: 10.1111/tid.13120. Epub 2019 Jun 14.PMID: 31124247

    Lepak AJ, Zhao M (graduate student), Marchillo K, VanHecker J, Andes DR.In Vivo Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e02058-19. doi: 10.1128/AAC.02058-19. Print 2020 Jan 27.PMID: 31712210

    Lepak AJ, Zhao M (graduate student), Andes DR.  WCK 5222 (Cefepime/Zidebactam) Pharmacodynamic Target Analysis against Metallo-β-lactamase producing Enterobacteriaceae in the Neutropenic Mouse Pneumonia Model. Antimicrob Agents Chemother. 2019 Oct 7;63(12):e01648-19. doi: 10.1128/AAC.01648-19. Online ahead of print.PMID: 31591114 

    Lepak AJ, Zhao M (graduate student), Andes DR. Determination of Pharmacodynamic Target Exposures for Rezafungin against Candida tropicalis and Candida dubliniensis in the Neutropenic Mouse Disseminated Candidiasis Model. Antimicrob Agents Chemother. 2019 Oct 22;63(11):e01556-19. doi: 10.1128/AAC.01556-19. Print 2019 Nov.PMID: 31481440 

    Dominguez EG (graduate student), Zarnowski R, Choy HL, Zhao M, Sanchez H, Nett JE, Andes DR. Conserved Role for Biofilm Matrix Polysaccharides in Candida auris Drug Resistance. mSphere. 2019 Jan 2;4(1):e00680-18. doi: 10.1128/mSphereDirect.00680-18.PMID: 30602527

    Zhao M (graduate student), Lepak AJ, Marchillo K, Andes DR. In Vivo Pharmacodynamic Target Determination for Delafloxacin against Klebsiella pneumoniae and Pseudomonas aeruginosa in the Neutropenic Murine Pneumonia Model. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01131-19. doi: 10.1128/AAC.01131-19. Print 2019 Oct.PMID: 31332063 

    Lepak AJ, Zhao M (graduate student), Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00624-19. doi: 10.1128/AAC.00624-19. Print 2019 Jul.PMID: 31036691

    Zhao M (graduate student), Lepak AJ, Marchillo K, Vanhecker J, Sanchez H, Ambrose PG, Andes DR.  APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02372-18. doi: 10.1128/AAC.02372-18. Print 2019 Apr.PMID: 30670426

    McBride JA (fellow), Gauthier GM, Klein BS. Turning on virulence: Mechanisms that underpin the morphologic transition and pathogenicity of Blastomyces. Virulence. 2019 Dec;10(1):801-809. doi: 10.1080/21505594.2018.1449506. Epub 2018 Aug 1.PMID: 29532714 

    Matchett C, Djamali A, Mandelbrot D, Saddler C (fellow), Parajuli S. Nocardia infection in kidney transplant recipients: A single-center experience. C, Djamali A, Mandelbrot D, Saddler C, Parajuli S.Transpl Infect Dis. 2019 Dec;21(6):e13192. doi: 10.1111/tid.13192. Epub 2019 Nov 1.PMID: 31596020

    Jorgenson MR, Descourouez JL, Yang DY, Leverson GE, Saddler CM (fellow), Smith JA, Safdar N, Mandlebrot DA, Redfield RR. Epidemiology, Risk Factors, and Outcomes After Early Posttransplant Clostridiodes difficile Infection in Renal Transplant Recipients. Ann Pharmacother. 2019 Oct;53(10):1020-1025. doi: 10.1177/1060028019845003. Epub 2019 Apr 21.PMID: 31007034

    Jorgenson MR, Descourouez JL, Cardinale B, Lyu B, Astor BC, Garg N, Saddler CM (fellow), Smith JA, Mandelbrot DA.  Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes. Transpl Infect Dis. 2019 Jun;21(3):e13080. doi: 10.1111/tid.13080. Epub 2019 Apr 16.PMID: 30891915

    Rolak S, Di Bartolomeo S, Jorgenson MR, Saddler CM (fellow), Singh T, Astor BC, Parajuli S. Outcomes of Norovirus diarrheal infections and Clostridioides difficile infections in kidney transplant recipients: A single-center retrospective study. Transpl Infect Dis. 2019 Apr;21(2):e13053. doi: 10.1111/tid.13053. Epub 2019 Feb 11.PMID: 30689283

    Lepak AJ, Zhao M (graduate student), Liu Q, Wang P, Wang Y, Bader JC, Ambrose PG, Andes DR. Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02404-18. doi: 10.1128/AAC.02404-18. Print 2019 Mar.PMID: 30559140 

    Kates AE, Tischendorf JS (fellow), Schweizer M, Herwaldt L, Samore M, Dukes KC, Gerding DN, Diekema DJ, Safdar N. Research Agenda for Microbiome Based Research for Multidrug-resistant Organism Prevention in the Veterans Health Administration System. Infect Control Hosp Epidemiol. 2018 Feb;39(2):202-209. doi: 10.1017/ice.2017.311.PMID: 29417924

    Lepak AJ, Zhao M (graduate student), Andes DR. Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e01572-18. doi: 10.1128/AAC.01572-18. Print 2018 Nov.PMID: 30181375

    Zarnowski R, Sanchez H, Covelli AS (graduate student), Dominguez E, Jaromin A, Bernhardt J, Mitchell KF, Heiss C, Azadi P, Mitchell A, Andes DR. Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. PLoS Biol. 2018 Oct 8;16(10):e2006872. doi: 10.1371/journal.pbio.2006872. eCollection 2018 Oct.PMID: 30296253 

    Zhao M (graduate student), Lepak AJ, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e01067-18. doi: 10.1128/AAC.01067-18. Print 2018 Sep.PMID: 29987156 

    Hoyer AR (undergraduate), Johnson CJ, Hoyer MR, Kernien JF (graduate student), Nett JE. Echinocandin Treatment of Candida albicans Biofilms Enhances Neutrophil Extracellular Trap Formation. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00797-18. doi: 10.1128/AAC.00797-18. Print 2018 Sep.PMID: 29987146

    Dominguez E (graduate student), Zarnowski R, Sanchez H, Covelli AS, Westler WM, Azadi P, Nett J, Mitchell AP, Andes DR. Conservation and Divergence in the Candida Species Biofilm Matrix Mannan-Glucan Complex Structure, Function, and Genetic Control. mBio. 2018 Apr 3;9(2):e00451-18. doi: 10.1128/mBio.00451-18.PMID: 29615504 

    Kernien JF (graduate student), Snarr BD, Sheppard DC, Nett JE. The Interface between Fungal Biofilms and Innate Immunity. Front Immunol. 2018 Jan 10;8:1968. doi: 10.3389/fimmu.2017.01968. eCollection 2017.PMID: 29375581 

    Johnson CJ, Davis JM (fellow), Huttenlocher A, Kernien JF, Nett JE. Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack. mBio. 2018 Aug 21;9(4):e01403-18. doi: 10.1128/mBio.01403-18.PMID: 30131360

    Zhao M (graduate student), Lepak AJ, VanScoy B, Bader JC, Marchillo K, Vanhecker J, Ambrose PG, Andes DR. In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02542-17. doi: 10.1128/AAC.02542-17. Print 2018 Apr.PMID: 29378706

    McBride JA (fellow), Lepak AJ, Dhaliwal G, Saint S, Safdar N. The Wrong Frame of Mind. N Engl J Med. 2018 May 3;378(18):1716-1721. doi: 10.1056/NEJMcps1710814.PMID: 29719187 

    Lepak AJ, Zhao M (graduate student), VanScoy B, Ambrose PG, Andes DR. Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design. Antimicrob Agents Chemother. 2018 Jan 25;62(2):e02154-17. doi: 10.1128/AAC.02154-17. Print 2018 Feb.PMID: 29203480 

    Thompson KM, Sterkel AK, McBride JA (fellow), Corliss RF. The Shock of Strep: Rapid Deaths Due to Group a Streptococcus. Acad Forensic Pathol. 2018 Mar;8(1):136-149. doi: 10.23907/2018.010. Epub 2018 Mar 7.PMID: 31240031

    Garg N, Jorgenson M, Descourouez J, Saddler CM (fellow), Parajuli S, Astor BC, Djamali A, Mandelbrot D. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes. BMC Nephrol. 2018 Nov 21;19(1):332. doi: 10.1186/s12882-018-1142-8.PMID: 30463516 

    Misch EA, Saddler C (fellow), Davis JM. Skin and Soft Tissue Infections Due to Nontuberculous Mycobacteria. Curr Infect Dis Rep. 2018 Mar 19;20(4):6. doi: 10.1007/s11908-018-0611-3.PMID: 29556857 

    Splinter LE, Kerstenetzky L, Jorgenson MR, Descourouez JL, Leverson GE, Saddler CM (fellow), Smith JA, Safdar N, Redfield RR. Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients. Ann Pharmacother. 2018 Feb;52(2):113-119. doi: 10.1177/1060028017727756. Epub 2017 Aug 26.PMID: 28844154

    Barker AK, Zellmer C, Tischendorf J (fellow), Duster M, Valentine S, Wright MO, Safdar N. On the hands of patients with Clostridium difficile: A study of spore prevalence and the effect of hand hygiene on C difficile removal. Am J Infect Control. 2017 Oct 1;45(10):1154-1156. doi: 10.1016/j.ajic.2017.03.005.PMID: 28964347 

    Lepak AJ, Zhao M (graduate student), Berkow EL, Lockhart SR, Andes DR. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00791-17. doi: 10.1128/AAC.00791-17. Print 2017 Aug.PMID: 28584152 

    McBride JA (fellow), Sterkel AK, Rehrauer WM, Smith JA. First described case of prosthetic joint infection with Clostridium disporicum. Anaerobe. 2017 Dec;48:56-58. doi: 10.1016/j.anaerobe.2017.06.022. Epub 2017 Jul 1.PMID: 28673848

    Brennan MB, Allen GO, Ferguson PD, McBride JA (fellow), Crnich CJ, Smith MA  The Association Between Geographic Density of Infectious Disease Physicians and Limb Preservation in Patients With Diabetic Foot Ulcers. Open Forum Infect Dis. 2017 Feb 20;4(1):ofx015. doi: 10.1093/ofid/ofx015. eCollection 2017 Winter.PMID: 28480286 

    Shirley D, Scholtz H (fellow), Osterby K, Musuuza J, Fox B, Safdar N. Optimizing Inpatient Urine Culture Ordering Practices Using the Electronic Medical Record: A Pilot Study. Infect Control Hosp Epidemiol. 2017;38(4):486-488. doi:10.1017/ice.2016.301

    Johnson CJ, Kernien JF (graduate student), Hoyer AR, Nett JE. Mechanisms involved in the triggering of neutrophil extracellular traps (NETs) by Candida glabrata during planktonic and biofilm growth. Sci Rep. 2017 Oct 12;7(1):13065. doi: 10.1038/s41598-017-13588-6.PMID: 29026191

    McBride JA (fellow), Striker R. Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health? PLoS Pathog. 2017 Nov 2;13(11):e1006624. doi: 10.1371/journal.ppat.1006624. eCollection 2017 Nov.PMID: 29095912 

    Brennan MB, Allen GO, Ferguson PD, McBride JA (fellow), Crnich CJ, Smith MA. The Association Between Geographic Density of Infectious Disease Physicians and Limb Preservation in Patients With Diabetic Foot Ulcers. Open Forum Infect Dis. 2017 Feb 20;4(1):ofx015. doi: 10.1093/ofid/ofx015. eCollection 2017 Winter.PMID: 28480286

    Zhao M (graduate student), Lepak AJ, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Target Assessment of Eravacycline against Escherichia coli in a Murine Thigh Infection Model. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00250-17. doi: 10.1128/AAC.00250-17. Print 2017 Jul.PMID: 28416552 

    Kernien JF (graduate student), Johnson CJ, Nett JE. Conserved Inhibition of Neutrophil Extracellular Trap Release by Clinical Candida albicans Biofilms. Version 2. J Fungi (Basel). 2017 Sep;3(3):49. doi: 10.3390/jof3030049. Epub 2017 Sep 6.PMID: 28944225 

    McBride JA (fellow), Gauthier GM, Klein BS. Clinical Manifestations and Treatment of Blastomycosis. Clin Chest Med. 2017 Sep;38(3):435-449. doi: 10.1016/j.ccm.2017.04.006. Epub 2017 Jun 12.PMID: 28797487 

    Lepak AJ, Zhao M (graduate student), Andes DR. Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00281-17. doi: 10.1128/AAC.00281-17. Print 2017 Jul.PMID: 28416551 

    McElligott M, Welham G, Pop-Vicas A, Taylor L (fellow), Crnich CJ. Antibiotic Stewardship in Nursing Facilities. Infect Dis Clin North Am. 2017 Dec;31(4):619-638. doi: 10.1016/j.idc.2017.07.008.PMID: 29079152 

    Lepak AJ, Zhao M (graduate student), VanScoy B, Taylor DS, Ellis-Grosse E, Ambrose PG, Andes DR. In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017 May 24;61(6):e00476-17. doi: 10.1128/AAC.00476-17. Print 2017 Jun.PMID: 28396549

    Lepak AJ, Zhao M (graduate student), Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02368-16. doi: 10.1128/AAC.02368-16. Print 2017 May.PMID: 28193651 


    Arriola V, Tischendorf J (fellow), Musuuza J, Barker A, Rozelle JW, Safdar N. Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis. Infect Control Hosp Epidemiol. 2016 Dec;37(12):1408-1417. doi: 10.1017/ice.2016.194. Epub 2016 Sep 28.PMID: 27677811 

    Tischendorf J (fellow), de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review. Am J Infect Control. 2016 May 1;44(5):539-43. doi: 10.1016/j.ajic.2015.12.005. Epub 2016 Feb 15.PMID: 26899297 

    Zhao M (graduate student), Lepak AJ, Andes DR. Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents. Bioorg Med Chem. 2016 Dec 15;24(24):6390-6400. doi: 10.1016/j.bmc.2016.11.008. Epub 2016 Nov 9.PMID: 27887963 

    Johnson CJ, Cabezas-Olcoz J, Kernien JF (graduate student), Wang SX, Beebe DJ, Huttenlocher A, Ansari H, Nett JE. The Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular Traps. PLoS Pathog. 2016 Sep 13;12(9):e1005884. doi: 10.1371/journal.ppat.1005884. eCollection 2016 Sep.PMID: 27622514

    Chopra T, Awali RA, Biedron C, Vallin E, Bheemreddy S, Saddler CM (fellow), Mullins K, Echaiz JF, Bernabela L, Severson R, Marchaim D, Lephart P, Johnson L, Thyagarajan R, Kaye KS, Alangaden G. Predictors of Clostridium difficile infection-related mortality among older adults. Am J Infect Control. 2016 Nov 1;44(11):1219-1223. doi: 10.1016/j.ajic.2016.04.231. Epub 2016 Jul 14.PMID: 27424303

    Jindai K (fellow), Sterkel AK, Reed KD, Crnich CJ. Limb Embolism in a 52-Year-Old Woman.Clin Infect Dis. 2016 May 15;62(10):1320-1. doi: 10.1093/cid/ciw081.PMID: 27118830

    Barocas JA (resident), Linas BP, Kim AY, Fangman J, Westergaard RP. Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs. Open Forum Infect Dis. 2016 Apr 6;3(2):ofw075. doi: 10.1093/ofid/ofw075. eCollection 2016 Mar.PMID: 27191007 

    Safdar N, Odden A, Abad CL, Thapa R (fellow), Saint S. Clinical problem-solving. In sight and out of mind. N Engl J Med. 2015 Jun 4;372(23):2218-23. doi: 10.1056/NEJMcps1413402.PMID: 26039603 

    Brennan MB (fellow), Barocas JA (resident), Crnich CJ, Hess TM, Kolehmainen CJ, Sosman JM, Sethi AK. "Oops! I forgot HIV": resident physician self-audits and universal HIV screening. J Infect Public Health. 2015 Mar-Apr;8(2):161-9. doi: 10.1016/j.jiph.2014.08.010. Epub 2014 Sep 29.PMID: 25277258

    Barocas JA (resident), Erlandson KM, Belzer BK, Hess T, Sosman J. Advance directives among people living with HIV: room for improvement. AIDS Care. 2015;27(3):370-7. doi: 10.1080/09540121.2014.963019. Epub 2014 Oct 13.PMID: 25307722

    Jindai K (fellow), Kunzer B, Van TT, Striker R. Human immunodeficiency virus testing pitfalls and clinical suspicion. Am J Emerg Med. 2014 Nov;32(11):1442.e1-2. doi: 10.1016/j.ajem.2014.04.017. Epub 2014 Apr 18.PMID: 24856744

    Nett JE (fellow), Cabezas-Olcoz J, Marchillo K, Mosher DF, Andes DR. Targeting Fibronectin To Disrupt In Vivo Candida albicans Biofilms. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3152-5. doi: 10.1128/AAC.03094-15. Print 2016 May.PMID: 26902759 

    Nett JE (fellow), Andes DR. Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infect Dis Clin North Am. 2016 Mar;30(1):51-83. doi: 10.1016/j.idc.2015.10.012. Epub 2015 Dec 29.PMID: 26739608 

    Nett JE (fellow), Andes DR. Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs. Microbiol Spectr. 2015 Jun;3(3):E30. doi: 10.1128/microbiolspec.MB-0008-2014.PMID: 26397003

    Nett JE (fellow), Zarnowski R, Cabezas-Olcoz J, Brooks EG, Bernhardt J, Marchillo K, Mosher DF, Andes DR. Host contributions to construction of three device-associated Candida albicans biofilms. Infect Immun. 2015 Dec;83(12):4630-8. doi: 10.1128/IAI.00931-15. Epub 2015 Sep 14.PMID: 26371129 

    Fox EP, Bui CK, Nett JE (fellow), Hartooni N, Mui MC, Andes DR, Nobile CJ, Johnson AD. An expanded regulatory network temporally controls Candida albicans biofilm formation. Version 2. Mol Microbiol. 2015 Jun;96(6):1226-39. doi: 10.1111/mmi.13002. Epub 2015 Apr 23.PMID: 25784162 

    Mitchell KF (graduate student), Zarnowski R, Sanchez H, Edward JA, Reinicke EL, Nett JE (fellow), Mitchell AP, Andes DR.Community participation in biofilm matrix assembly and function. Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4092-7. doi: 10.1073/pnas.1421437112. Epub 2015 Mar 13.

    Nett JE (fellow), Brooks EG, Cabezas-Olcoz J, Sanchez H, Zarnowski R, Marchillo K, Andes DR. Rat indwelling urinary catheter model of Candida albicans biofilm infection. Infect Immun. 2014 Dec;82(12):4931-40. doi: 10.1128/IAI.02284-14. Epub 2014 Sep 2.PMID: 25183731

    Abad CL (fellow), Moseley RH, Crnich CJ, Saint S, Safdar N. Clinical problem-solving. A gut instinct. N Engl J Med. 2014 Aug 7;371(6):560-4. doi: 10.1056/NEJMcps1202137.PMID: 25099581

    Zarnowski R, Westler WM, Lacmbouh GA, Marita JM, Bothe JR, Bernhardt J, Lounes-Hadj Sahraoui A, Fontaine J, Sanchez H, Hatfield RD, Ntambi JM, Nett JE (fellow), Mitchell AP, Andes DR. Novel entries in a fungal biofilm matrix encyclopedia. mBio. 2014 Aug 5;5(4):e01333-14. doi: 10.1128/mBio.01333-14.PMID: 25096878 

    Brennan MB (fellow), Kolehmainen C, Barocas J (resident), Isaac C, Crnich CJ, Sosman JM. Barriers and facilitators of universal HIV screening among internal medicine residents. WMJ. 2013 Oct;112(5):199-205.PMID: 24734414 

    Taff HT (medical student)Nett JE (fellow), Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR.A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog. 2012;8(8):e1002848. doi: 10.1371/journal.ppat.1002848. Epub 2012 Aug 2.PMID: 22876186 

    Finkel JS, Xu W, Huang D, Hill EM, Desai JV, Woolford CA, Nett JE (fellow)Taff H (medical student), Norice CT, Andes DR, Lanni F, Mitchell AP. Portrait of Candida albicans adherence regulators. PLoS Pathog. 2012 Feb;8(2):e1002525. doi: 10.1371/journal.ppat.1002525. Epub 2012 Feb 16.PMID: 22359502 

    Nett JE (fellow), Marchillo K, Andes DR. Modeling of fungal biofilms using a rat central vein catheter. Methods Mol Biol. 2012;845:547-56. doi: 10.1007/978-1-61779-539-8_40.PMID: 22328403 
    Nobile CJ, Fox EP, Nett JE (fellow), Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell. 2012 Jan 20;148(1-2):126-38. doi: 10.1016/j.cell.2011.10.048.PMID: 22265407 

    Robbins N, Uppuluri P, Nett J (resident), Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog. 2011 Sep;7(9):e1002257. doi: 10.1371/journal.ppat.1002257. Epub 2011 Sep 8.PMID: 21931556

    Nett JE (resident), Sanchez H, Cain MT, Ross KM, Andes DR. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryot Cell. 2011 Dec;10(12):1660-9. doi: 10.1128/EC.05126-11. Epub 2011 Jun 10.PMID: 21666076

    Taff HT (medical student)Nett JE (resident), Andes DR. Comparative analysis of Candida biofilm quantitation assays. Med Mycol. 2012 Feb;50(2):214-8. doi: 10.3109/13693786.2011.580016. Epub 2011 May 4.PMID: 21539503 

    Nett JE (resident), Cain MT (undergraduate), Crawford K, Andes DR. Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay. J Clin Microbiol. 2011 Apr;49(4):1426-33. doi: 10.1128/JCM.02273-10. Epub 2011 Jan 12.PMID: 21227984

    Nett JE (resident), Marchillo K, Spiegel CA, Andes DR. Development and validation of an in vivo Candida albicans biofilm denture model. Infect Immun. 2010 Sep;78(9):3650-9. doi: 10.1128/IAI.00480-10. Epub 2010 Jul 6.PMID: 20605982

    Nett JE (resident), Crawford K, Marchillo K, Andes DR. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob Agents Chemother. 2010 Aug;54(8):3505-8. doi: 10.1128/AAC.00227-10. Epub 2010 Jun 1.PMID: 20516280

    Additional Research Opportunities